Automated profiling to improve identification of diabetes patients
PheMAP: Measured, Automated Profile to Facilitate High Throughput Phenotyping
This study is testing a new way to help doctors find and understand diabetes patients better by using electronic health records, so they can provide more personalized care and improve treatment outcomes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10756150 on NIH RePORTER |
What this research studies
This research focuses on developing a new method called PheMAP, which aims to enhance the accuracy of identifying individuals with diabetes using electronic health records (EHRs). By leveraging publicly available information and advanced algorithms, the project seeks to create standardized profiles that can be applied across different EHR systems. This approach aims to streamline the process of phenotyping, making it faster and more reliable for healthcare providers to recognize patients with specific traits, such as various forms of diabetes. Ultimately, this could lead to better-targeted treatments and improved patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with various forms of type 2 diabetes, including adult-onset and ketosis-resistant diabetes.
Not a fit: Patients with forms of diabetes that are not included in the study or those without electronic health records may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and efficient identification of diabetes patients, enabling personalized treatment strategies.
How similar studies have performed: Other research has shown promise in using automated approaches for phenotyping, suggesting that this method could be a significant advancement in the field.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Wei, Wei-Qi — Vanderbilt University Medical Center
- Study coordinator: Wei, Wei-Qi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.